RCAG
DGX icon

Rehmann Capital Advisory Group’s Quest Diagnostics DGX Stock Holding History

Rehmann Capital Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,694
Closed -$317K – 662
2025
Q3 		$317K Sell
1,694
-256
-13% -$45.4K 0.02% 486
2025
Q2 		$350K Sell
1,950
-1,286
-40% -$223K 0.02% 437
2025
Q1 		$548K Sell
3,236
-1,346
-29% -$221K 0.03% 342
2024
Q4 		$691K Buy
4,582
+132
+3% +$20.5K 0.04% 274
2024
Q3 		$696K Sell
4,450
-1,803
-29% -$269K 0.05% 273
2024
Q2 		$855K Sell
6,253
-332
-5% -$45.5K 0.06% 231
2024
Q1 		$877K Buy
6,585
+497
+8% +$64.5K 0.07% 220
2023
Q4 		$840K Sell
6,088
-845
-12% -$111K 0.07% 214
2023
Q3 		$845K Buy
6,933
+549
+9% +$73.1K 0.08% 198
2023
Q2 		$897K Sell
6,384
-706
-10% -$97.3K 0.08% 201
2023
Q1 		$1M Sell
7,090
-358
-5% -$51.2K 0.09% 186
2022
Q4 		$1.17M Sell
7,448
-678
-8% -$97.4K 0.12% 152
2022
Q3 		$997K Buy
8,126
+44
+0.5% +$5.79K 0.11% 160
2022
Q2 		$1.07M Sell
8,082
-156
-2% -$21.3K 0.12% 153
2022
Q1 		$1.13M Sell
8,238
-83
-1% -$11.6K 0.11% 168
2021
Q4 		$1.44M Buy
8,321
+267
+3% +$40.6K 0.13% 138
2021
Q3 		$1.19M Buy
8,054
+55
+0.7% +$8.05K 0.11% 163
2021
Q2 		$1.05M Buy
7,999
+317
+4% +$41.5K 0.1% 173
2021
Q1 		$990K Buy
7,682
+574
+8% +$70.7K 0.1% 164
2020
Q4 		$847K Buy
+7,108
New +$867K 0.1% 179
2019
Q3 		$15K Hold
140
– – ﹤0.01% 943
2019
Q2 		$14.3K Buy
140
+4
+3% +$384 ﹤0.01% 1239
2019
Q1 		$12.3K Buy
136
+44
+48% +$3.81K ﹤0.01% 1264
2018
Q4 		$7.7K Hold
92
– – ﹤0.01% 1138
2018
Q3 		$9.96K Hold
92
– – ﹤0.01% 1366
2018
Q2 		$10.1K Buy
92
+45
+96% +$4.69K ﹤0.01% 1336
2018
Q1 		$5K Buy
+47
New +$4.81K ﹤0.01% 1509

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rehmann Capital Advisory Group's DGX Position: Q4 2025 in Review

Rehmann Capital Advisory Group sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,694 shares — an estimated $317K sold.

Rehmann Capital Advisory Group first reported a position in DGX in Q1 2018 and held it in 27 quarters. The position peaked at $1.44M in Q4 2021. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Rehmann Capital Advisory Group reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 1,694 Quest Diagnostics shares in Q4 2025, an estimated $317K.
  • Rehmann Capital Advisory Group first reported a position in Quest Diagnostics in Q1 2018 and held it in 27 quarters.
  • Rehmann Capital Advisory Group's Quest Diagnostics position peaked at $1.44M in Q4 2021.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Rehmann Capital Advisory Group's 13F filing for Q4 2025, filed 4 Mar 2026.